Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.81M Buy
201,962
+11,724
+6% +$183K ﹤0.01% 1909
2026
Q1
$2.39M Buy
190,238
+2,424
+1% +$24.6K ﹤0.01% 1949
2025
Q4
$1.63M Buy
187,814
+2,068
+1% +$17.9K ﹤0.01% 1959
2025
Q3
$1.74M Buy
185,746
+6,594
+4% +$61.4K ﹤0.01% 1811
2025
Q2
$1.61M Buy
179,152
+103,783
+138% +$828K ﹤0.01% 2236
2025
Q1
$657K Buy
+75,369
New +$759K ﹤0.01% 2439
2024
Q2
Sell
-82,597
Closed -$449K 2797
2024
Q1
$449K Hold
82,597
﹤0.01% 2319
2023
Q4
$606K Buy
82,597
+10,500
+15% +$69.2K ﹤0.01% 2256
2023
Q3
$593K Sell
72,097
-12,654
-15% -$112K ﹤0.01% 2224
2023
Q2
$1.34M Hold
84,751
﹤0.01% 1870
2023
Q1
$1.34M Sell
84,751
-2,000
-2% -$34.7K ﹤0.01% 1870
2022
Q4
$1.63M Buy
86,751
+1,700
+2% +$34.1K ﹤0.01% 1627
2022
Q3
$1.67M Buy
+85,051
New +$1.86M ﹤0.01% 1701
2022
Q2
Sell
-54,809
Closed -$1.01M 2687
2022
Q1
$1.01M Buy
54,809
+373
+0.7% +$7.39K ﹤0.01% 2136
2021
Q4
$1.24M Buy
54,436
+1,309
+2% +$26.5K ﹤0.01% 2093
2021
Q3
$997K Buy
53,127
+505
+1% +$10.6K ﹤0.01% 2165
2021
Q2
$1.09M Sell
52,622
-1,672
-3% -$32.3K ﹤0.01% 2159
2021
Q1
$906K Hold
54,294
﹤0.01% 2142
2020
Q4
$802K Hold
54,294
﹤0.01% 2092
2020
Q3
$557K Buy
54,294
+8,833
+19% +$100K ﹤0.01% 2094
2020
Q2
$497K Sell
45,461
-335
-0.7% -$3.46K ﹤0.01% 2133
2020
Q1
$352K Sell
45,796
-5,688
-11% -$48.6K ﹤0.01% 2107
2019
Q4
$509K Buy
51,484
+3,433
+7% +$32.7K ﹤0.01% 2228
2019
Q3
$545K Buy
48,051
+8,550
+22% +$102K ﹤0.01% 2252
2019
Q2
$602K Buy
39,501
+6,867
+21% +$110K ﹤0.01% 2125
2019
Q1
$447K Buy
32,634
+20,334
+165% +$281K ﹤0.01% 2152
2018
Q4
$132K Sell
12,300
-10,498
-46% -$143K ﹤0.01% 2487
2018
Q3
$402K Hold
22,798
﹤0.01% 2173
2018
Q2
$339K Hold
22,798
﹤0.01% 2255
2018
Q1
$355K Buy
+22,798
New +$380K ﹤0.01% 2145
2017
Q4
Sell
-8,350
Closed -$200K 2574
2017
Q3
$200K Buy
+8,350
New +$185K ﹤0.01% 2258
2016
Q4
Sell
-23,898
Closed -$457K 2499
2016
Q3
$457K Hold
23,898
﹤0.01% 2027
2016
Q2
$446K Hold
23,898
﹤0.01% 2012
2016
Q1
$483K Sell
23,898
-100
-0.4% -$1.85K ﹤0.01% 1942
2015
Q4
$413K Sell
23,998
-2,700
-10% -$43K ﹤0.01% 2154
2015
Q3
$390K Hold
26,698
﹤0.01% 2134
2015
Q2
$434K Buy
26,698
+4,500
+20% +$77.2K ﹤0.01% 2129
2015
Q1
$414K Buy
22,198
+1,200
+6% +$25.5K ﹤0.01% 2085
2014
Q4
$458K Hold
20,998
﹤0.01% 1990
2014
Q3
$431K Hold
20,998
﹤0.01% 1955
2014
Q2
$474K Sell
20,998
-266,100
-93% -$6.03M ﹤0.01% 1930
2014
Q1
$7.01M Buy
287,098
+267,200
+1,343% +$6.88M 0.01% 951
2013
Q4
$537K Buy
19,898
+200
+1% +$5.03K ﹤0.01% 1775
2013
Q3
$525K Hold
19,698
﹤0.01% 1760
2013
Q2
$485K Buy
+19,698
New +$436K ﹤0.01% 1722

Other funds holding ADTN

UBS AM's ADTN Position: Q2 2026 in Review

UBS AM increased its Adtran (ADTN) stake by 6.2% in Q2 2026, buying an estimated $183K and bringing the position to 201,962 shares worth $2.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1909.

UBS AM first reported a position in ADTN in Q2 2013 and has held it in 45 quarters since. The position peaked at $7.01M in Q1 2014. 249 funds tracked by Wall St. Rank hold ADTN as of Q2 2026.

  • UBS AM held 201,962 shares of Adtran worth $2.81M as of Q2 2026.
  • UBS AM bought 11,724 Adtran shares in Q2 2026, an estimated $183K.
  • Adtran made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1909 holding.
  • UBS AM first reported a position in Adtran in Q2 2013 and has held it in 45 quarters since.
  • UBS AM's Adtran position peaked at $7.01M in Q1 2014.
  • 249 funds tracked by Wall St. Rank held Adtran as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.